As of November 2025, according to Globus Medical's current financial statements, the company's 12-month EPS is $2.63. For the year 2024, the company recorded an earnings per share (EPS) of $0.76, which marks a drop compared to its EPS of $1.09 in 2023. Globus Medical's earnings per share for the quarterly report ending on Jun 30, 2025 reached $1.5.
The annual EPS for the year 2024 was $0.76, a drop of 30.3% from $1.09 in 2023. For the fiscal quarter that ended on Jun 30, 2025, the per-share earnings was $1.5, showing a 552.2% increase from the same quarter last year. For the twelve months ending June 2025, the EPS is $2.63. For the year 2023, the yearly earnings per share was $1.09, marking a decrease of 42.3% from 2022.
Globus Medical has registered an increase in EPS of 552.2% during the last 12 months (YoY, quarterly). In the last three years, GMED recorded an average annual EPS growth rate of -19.9%. Globus Medical had an average annual EPS growth rate of -13.5% during the last 5 years. Across the last decade, GMED had an average annual EPS growth of -2.5%.
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| GMED Globus Medical Inc | 23.39 | -30.3% | -19.9% | -13.5% |
| SYK Stryker Corp | 46.33 | -5.8% | 14.1% | 7.1% |
| OFIX Orthofix Medical Inc | N/A | 19.9% | N/A | N/A |
| ATEC Alphatec Holdings Inc | N/A | 26.6% | N/A | N/A |
All data is based on quarterly TTM periods, unless otherwise specified.